Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Bristol Featured PhD Programmes
University of Edinburgh Featured PhD Programmes
Swansea University Featured PhD Programmes
University College London Featured PhD Programmes
University of Manchester Featured PhD Programmes
"ovarian" AND "cancer"×
10 miles

ovarian cancer PhD Projects, Programs & Scholarships

We have 14 ovarian cancer PhD Projects, Programs & Scholarships

  • "ovarian" AND "cancer" ×
  • clear all
Order by 
Showing 1 to 10 of 14
  Activation of targeted DNA Damage Response as a novel therapy for Ovarian Cancer
  Dr E. Sanij, Prof R. Pearson
Applications accepted all year round
High-grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of ovarian cancer and accounts for 70% of all ovarian cancer deaths.
  Therapy-induced senescence and stemness in ovarian cancer
  Prof R. Pearson, Dr K Chan
Applications accepted all year round
Cellular senescence is a stress response characterized by a robust cell cycle arrest and is a brake for malignant transformation.
  Targeting the Achilles’ heel – dissecting drug resistance in ovarian cancer
  Dr G Smith, Dr M Ferguson
Applications accepted all year round
Ovarian cancer, the most common cause of gynaecological cancer death, is frequently diagnosed when the disease is already advanced, when surgery is not always possible.
  Identification and functional characterisation of BRIT1/MCPH1 synthetic lethal genes to treat breast and ovarian cancer
  Dr S Bell, Prof C A Johnson
Applications accepted all year round
Women who have undergone surgery for breast and ovarian cancer often have additional chemotherapy to kill residual cancer cells and prevent recurrence.
  Characterize the role of Treacle (TCOF1) in AKT-regulated ribosome biogenesis
  Prof R. Pearson, Dr J Kang
Applications accepted all year round
Ribosomes are essential for cell growth and proliferation, and their biogenesis requires exquisite regulation.
  (A*STAR) Can non-coding variants explain missing heritability in familial cancer?
  Prof B Newman, Prof G Evans, Dr M Smith
Application Deadline: 31 January 2019
Heterozygous germline variants in a number of tumour suppressor genes cause a spectrum of familial cancers, including early onset breast-ovarian cancer, and colorectal cancer.
  Application of data science to inherited genetic variants of apoptosis genes and susceptibility to breast cancer
  Prof A Cox, Dr K Walters
Application Deadline: 23 January 2019
Background. The identification of the breast and ovarian cancer genes BRCA1 and BRCA2 two decades ago has resulted in both improved patient risk assessment and the use of PARP-inhibitors for treatment.
  Inhibition of PRMT5 as a cancer therapy
  Dr K. Sheppard, Prof G. McArthur
Applications accepted all year round
Targeted therapy has had profound impact on outcomes for cancer patients.
  Parallels between wound healing and cancer – role of epithelial to mesenchymal transition (EMT)
  Research Group: Centre for Skin Sciences
  Dr M J Thornton, Prof A M Graham
Applications accepted all year round
Wound healing and cancer metastasis share common early signalling pathways that have led to the hypothesis that tumours are “wounds that do not heal”, a phrase first coined by Virchow in the 19th century.
  MRC DiMeN Doctoral Training Partnership: Application of data science to inherited genetic variants of apoptosis genes and susceptibility to breast cancer
  Prof A Cox, Dr A Droop, Dr K Walters
Application Deadline: 21 January 2019
The identification of the breast and ovarian cancer genes BRCA1 and BRCA2 two decades ago has resulted in both improved risk assessment for patients and the use of PARP-inhibitors for treatment.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.